About Zhejiang Huahai Pharmaceutical Company

The company takes the cause of human health as its mission, and is committed to providing high-quality medical and health products to patients around the world, continuously improving the accessibility of products and improving the quality of life of the public. The company is mainly engaged in R&D, production and sales of multi-dosage generic drugs, biopharmaceuticals, innovative drugs and specialty APIs. The company's products mainly include irbesartan hydrochlorothiazide tablets, losartan potassium tablets, irbesartan tablets, fosinepril, sodium tablets, rivaroxaban tablets, anisetan tablets, paroxetine hydrochloride tablets, sertraline hydrochloride tablets, risperidone tablets, dovaslazide tablets, olanzapine tablets, donepezil hydrochloride tablets, osestazovir phosphate capsules, voriconazole tablets, ligliptin tablets, dabigatran tablets, injectable methoprim tablets Sodium, esomeprazole magnesium enteric capsules, febuastat tablets, tofatib citrate tablets, torasemide injections. Company Honors: National Industry-Education Integrated Enterprise, National Key High-tech Enterprise, National Innovative Enterprise, National Technological Innovation Demonstration Enterprise.